在SARS-CoV-2感染期间调节TLR7,TYK2和OAS1的表达
Estíbaliz Alegría-Carrasco1, Marta Jaén-Castaño1, Pablo Delgado-Wicke1,2
1Molecular Biology Unit, La Princesa University Hospital and Health Research Institute (IIS-Princesa), Madrid, Spain.
低收费类受体7 (TLR7) 表达与严重的COVID-19相关. 这表明TLR7和OAS1基因表达模式可能表明SARS-CoV-2感染的疾病严重程度和病毒性.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 遗传学 遗传学 是一个
背景情况:
- 宿主对SARS-CoV-2的反应是多因素的,受遗传学和早期免疫信号的影响.
- 干扰素通路的激活对抗病毒防御至关重要,可能会影响COVID-19的结果.
- 这项研究研究了病毒传感和干扰素反应中的关键基因:TLR7,TYK2和OAS1.1.
研究的目的:
- 评估不同疾病严重程度的COVID-19患者中TLR7,TYK2和OAS1的基因表达.
- 确定基因表达水平与疾病严重程度和病毒性病症等临床参数之间的关联.
- 了解COVID-19期间这些基因表达的纵向变化.
主要方法:
- 来自157名COVID-19患者的人口和临床数据的分析.
- 用qPCR和数字PCR对外围血液单核细胞的基因表达和基因定型.
- 使用通用线性混合模型进行统计分析,包括单变量和多变量方法.
主要成果:
- 在严重的COVID-19病例中观察到较低的TLR7表达,随着时间的推移保持稳定,与轻度/中度病例不同,其下降.
- OAS1表达显示出与TLR7相似的趋势,而TYK2表达保持不变.
- 多变量分析将较低的TLR7表达与严重程度和病毒性病的增加联系起来;OAS1水平与较高的病毒性病相关.
结论:
- 减少TLR7表达是严重COVID-19的重要指标.
- 随着时间的推移,TLR7和OAS1基因表达动态受到疾病严重程度和病毒病的调节.
- 在严重病例中OAS1表达的持续性表明在正在进行的病毒复制中发挥了作用.
更多相关视频
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
相关概念视频
The JAK-STAT Signaling Pathway
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Translational Regulation
Regulation of the Unfolded Protein Response
Global Regulatory Systems
